Dr. Matthew Yurgelun explains what high risk means for pancreatic cancer, and outlines what you can do if you meet these criteria.
Dr. Venkata Akshintala outlines some of the precursors to pancreatic cancer that people should look out for.
A clinical trial for at-risk people is looking for biomarkers that can indicate pancreatic cancer is growing.
Dr. Peter Allen leads a clinical trial of chemoprevention–the use of a medication to prevent IPMNs from developing into pancreatic cancer.
Researchers are using blood samples to follow people considered at risk for developing pancreatic cancer in a trial looking for early detection biomarkers.
Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.
Have you or someone you love just been diagnosed with pancreatic cancer? Learn some basic facts about this disease from our FAQ.
A tumor registry studies the genetics of pancreatic cancer to determine risk factors for families.